Multivariate analysis that included RAS, PIK3CA, and BRAF tumor mutations and baseline prognostic variables revealed that liver metastasis, unresectable primary tumor, RAS and BRAF tumor mutations had independent prognostic value for early progression (Table 3). The gene discussed is BRAF; the disease is neoplasm.